248 related articles for article (PubMed ID: 23584023)
1. Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients.
Qiu Y; Zhou B; Su M; Baxter S; Zheng X; Zhao X; Yen Y; Jia W
Int J Mol Sci; 2013 Apr; 14(4):8047-61. PubMed ID: 23584023
[TBL] [Abstract][Full Text] [Related]
2. Orange juice affects acylcarnitine metabolism in healthy volunteers as revealed by a mass-spectrometry based metabolomics approach.
Moreira V; Brasili E; Fiamoncini J; Marini F; Miccheli A; Daniel H; Lee JJH; Hassimotto NMA; Lajolo FM
Food Res Int; 2018 May; 107():346-352. PubMed ID: 29580494
[TBL] [Abstract][Full Text] [Related]
3. Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer.
Gu H; Pan Z; Xi B; Asiago V; Musselman B; Raftery D
Anal Chim Acta; 2011 Feb; 686(1-2):57-63. PubMed ID: 21237308
[TBL] [Abstract][Full Text] [Related]
4. Serum lipidome screening in patients with stage I non-small cell lung cancer.
Klupczynska A; Plewa S; Kasprzyk M; Dyszkiewicz W; Kokot ZJ; Matysiak J
Clin Exp Med; 2019 Nov; 19(4):505-513. PubMed ID: 31264112
[TBL] [Abstract][Full Text] [Related]
5. Exploration of circulating metabolic signature of erythrodermic psoriasis based on LC-MS metabolomics.
Guo L; Wu C; Song B; Jin HZ
Exp Dermatol; 2024 May; 33(5):e15103. PubMed ID: 38794829
[TBL] [Abstract][Full Text] [Related]
6. Potential plasma lipid biomarkers in early-stage breast cancer.
Jiang N; Zhang G; Pan L; Yan C; Zhang L; Weng Y; Wang W; Chen X; Yang G
Biotechnol Lett; 2017 Nov; 39(11):1657-1666. PubMed ID: 28828718
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
9. High resolution mass spectrometry coupled with multivariate data analysis revealing plasma lipidomic alteration in ovarian cancer in Asian women.
Zhang Y; Liu Y; Li L; Wei J; Xiong S; Zhao Z
Talanta; 2016 Apr; 150():88-96. PubMed ID: 26838385
[TBL] [Abstract][Full Text] [Related]
10. A plasma metabolomic signature discloses human breast cancer.
Jové M; Collado R; Quiles JL; Ramírez-Tortosa MC; Sol J; Ruiz-Sanjuan M; Fernandez M; de la Torre Cabrera C; Ramírez-Tortosa C; Granados-Principal S; Sánchez-Rovira P; Pamplona R
Oncotarget; 2017 Mar; 8(12):19522-19533. PubMed ID: 28076849
[TBL] [Abstract][Full Text] [Related]
11. Identification of psoriasis vulgaris biomarkers in human plasma by non-targeted metabolomics based on UPLC-Q-TOF/MS.
Li SS; Liu Y; Li H; Wang LP; Xue LF; Yin GS; Wu XS
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3940-3950. PubMed ID: 31115022
[TBL] [Abstract][Full Text] [Related]
12. Prospective analysis of circulating metabolites and breast cancer in EPIC.
His M; Viallon V; Dossus L; Gicquiau A; Achaintre D; Scalbert A; Ferrari P; Romieu I; Onland-Moret NC; Weiderpass E; Dahm CC; Overvad K; Olsen A; Tjønneland A; Fournier A; Rothwell JA; Severi G; Kühn T; Fortner RT; Boeing H; Trichopoulou A; Karakatsani A; Martimianaki G; Masala G; Sieri S; Tumino R; Vineis P; Panico S; van Gils CH; Nøst TH; Sandanger TM; Skeie G; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Schmidt JA; Travis RC; Riboli E; Tsilidis KK; Christakoudi S; Gunter MJ; Rinaldi S
BMC Med; 2019 Sep; 17(1):178. PubMed ID: 31547832
[TBL] [Abstract][Full Text] [Related]
13. Identification of Lysophosphatidylcholines and Sphingolipids as Potential Biomarkers for Acute Aortic Dissection via Serum Metabolomics.
Zhou X; Wang R; Zhang T; Liu F; Zhang W; Wang G; Gu G; Han Q; Xu D; Yao C; Guo D; Fu W; Qi Y; Wang L
Eur J Vasc Endovasc Surg; 2019 Mar; 57(3):434-441. PubMed ID: 30087010
[TBL] [Abstract][Full Text] [Related]
14. High-Performance Liquid Chromatography-Mass Spectrometry-Based Lipid Metabolite Profiling of Acromegaly.
Wang M; Guo S; He M; Shao X; Feng L; Yu Y; Gong W; Liu Q; Melnikov V; Wang X; He Z; Jiang L; Chen M; Sun J; Cai J; Zhao Y; Li Y; Tritos NA; Hu Z; Zhang Z
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31930294
[TBL] [Abstract][Full Text] [Related]
15. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
[TBL] [Abstract][Full Text] [Related]
16. Aspects of transition cow metabolomics-Part III: Alterations in the metabolome of liver and blood throughout the transition period in cows with different liver metabotypes.
Schären M; Riefke B; Slopianka M; Keck M; Gruendemann S; Wichard J; Brunner N; Klein S; Snedec T; Theinert KB; Pietsch F; Rachidi F; Köller G; Bannert E; Spilke J; Starke A
J Dairy Sci; 2021 Aug; 104(8):9245-9262. PubMed ID: 34024605
[TBL] [Abstract][Full Text] [Related]
17. The decrease of some serum free amino acids can predict breast cancer diagnosis and progression.
Eniu DT; Romanciuc F; Moraru C; Goidescu I; Eniu D; Staicu A; Rachieriu C; Buiga R; Socaciu C
Scand J Clin Lab Invest; 2019; 79(1-2):17-24. PubMed ID: 30880483
[TBL] [Abstract][Full Text] [Related]
18. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive lipid profiling of plasma in patients with benign breast tumor and breast cancer reveals novel biomarkers.
Yang L; Cui X; Zhang N; Li M; Bai Y; Han X; Shi Y; Liu H
Anal Bioanal Chem; 2015 Jul; 407(17):5065-77. PubMed ID: 25651902
[TBL] [Abstract][Full Text] [Related]
20. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
